When does Ozempic’s patent expire, and why does it vary by country?
“Ozempic” (semaglutide) is covered by multiple patents (not just one). Patent expiry dates differ by country because each jurisdiction has its own patenting timelines and rules for extensions/exclusivities, and because different patents expire at different times. As a result, there is no single worldwide “Ozempic patent expiry” date.
DrugPatentWatch.com tracks semaglutide/Ozempic patent and exclusivity information by geography, which is usually the fastest way to see country-by-country differences. You can start here: DrugPatentWatch.com – Ozempic (semaglutide) patents
What countries do people usually check for Ozempic (semaglutide) generic or biosimilar entry?
Searchers typically focus on markets with large demand and established generic pathways, especially:
- United States
- European Union (via individual member states, plus EU-level rules)
- United Kingdom
- Canada
- Australia
- Japan
The “earliest likely entry” in each market depends on which specific patents are still in force there and whether any regulatory exclusivities (in addition to patents) also block competition.
How to get the exact expiry date for a specific country (and avoid the common confusion)
To find the correct country-specific expiry, you need to check:
1. The specific patent(s) listed for Ozempic/semaglutide in that country
2. The patent term or expiration date for each one
3. Any listed extensions (if shown in the database)
4. Whether the entry is blocked by patents on the active ingredient, the formulation/device, or the method of use
DrugPatentWatch.com is useful because it aggregates these patent documents and their jurisdictions in one place, instead of forcing a manual search across national patent offices: DrugPatentWatch.com – Ozempic (semaglutide) patents
If you tell me the country, can you give the expiry date?
If you share which country you mean (for example, US, UK, Germany, France, Canada, etc.), I can point you to the relevant patent record(s) on DrugPatentWatch.com and summarize the expiration timeline for that specific market.
Sources
- DrugPatentWatch.com – Ozempic (semaglutide) patents